Vasculitis - Epidemiology: Developments, Opportunities, Market Analysis, Future Trends!

1
EpiCast Report Vasculitis - Epidemiology
Forecast to 2024
Published on 01 January, 2016 Single
User Price 3995 No of Pages 98
The report focuses on global major leading
industry players with information such as company
profiles, product picture and specifications,
sales, market share and contact information.
Whats more, the EpiCast Report Vasculitis -
Epidemiology Forecast to 2024 development trends
and marketing channels are analyzed.
2
Summary Vasculitis is a group of heterogeneous
disorders affecting persons of both sexes and all
ages. These disorders are characterized by
inflammation and necrosis of the blood vessels
including the veins, arteries, and capillaries.
There are various forms of vasculitis, and their
clinical expressions may differ greatly in terms
of symptoms observed, severity and duration of
the disease depending on disease site and type of
blood vessels involved. Due to the lack of a
uniformly accepted classification criteria for
vasculitis, GlobalData epidemiologists obtained
data for each vasculitis disorder from studies
that categorized patients with vasculitis with
the Chapel Hill Consensus Conference (CHCC)
definitions.
3
In the 7MM, GlobalData epidemiologists forecast
that the diagnosed incident cases of vasculitis
(includes AAV, LVV, BD, and KD) for ages 15 and
older will increase from 82,019 diagnosed
incident cases in 2014 to 95,428 diagnosed
incident cases in 2024, at an Annual Growth Rate
(AGR) of 1.63 during the forecast period.
GlobalData epidemiologists forecast that the
diagnosed prevalent cases of selected vasculitis
disorders (includes AAV, TA, and BD) for ages 15
years and older will increase from 137,603
diagnosed prevalent cases in 2014 to 145,229
diagnosed prevalent cases in 2024, at an AGR of
0.55 during the forecast period.
Click Here To Check Complete Report
4
Scope - The Vasculitis EpiCast Report provides
an overview of the risk factors and global trends
of selected vasculitis disorders in the 7MM (US,
France, Germany, Italy, Spain, UK, and Japan).
The selected vasculitis disorders are
anti-neutrophil cytoplasmic antibod-associated
vasculitis (AAV) (microscopic polyangitis MPA,
granulomatosis with polyangitis GPA, and
eosinophilic granulomatosis with polyangitis
eGPA), large vessel vasculitis (LVV) (giant
cell arteritis GCA and Takayasu's arteritis
TA), Beh?ets disease (BD), and Kawasaki
disease (KD). The report includes a 10-year
epidemiological forecast for the diagnosed
incident cases of AAV, LVV, BD, and KD, as well
as the diagnosed prevalent cases of AAV, TA, and
BD. Age and sex segmentations are also provided.
Download Sample Brochure
5
Reasons to buy The Vasculitis EpiCast report
will allow you to - - Develop business
strategies by understanding the trends shaping
and driving the global vasculitis market. -
Quantify patient populations in the global
vasculitis market to improve product design,
pricing, and launch plans. - Organize sales and
marketing efforts by identifying the age groups
and sex that present the best opportunities for
vasculitis therapeutics in each of the markets
covered.
Make an Inquiry Before Buying
6
Key questions answered in this report  What
will the market size be in 2020 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors? You can request one free
hour of our analysts time when you purchase this
market report. Details are provided within the
report.
7
EpiCast Report Vasculitis - Epidemiology
Forecast to 2024
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the EpiCast Report Vasculitis - Epidemiology
Forecast to 2024 and future opportunities are
provided in the report.
Contact 1-302-684-6088 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of EpiCast Report
Vasculitis - Epidemiology Forecast to 2024